Browsing by Author Gray, Kathryn P

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)Citation
2013Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a "standard chemotherapy regimen": The CASA randomized trialCoates, Alan; Crivellari, Diana; Dellapasqua, S; et al, Various; Gianni, Lorenzo; Gray, Kathryn P; Lang, Istvan; Pinotti, Graziella; Price, Karen N; Puglisi, Fabio; Ribi, Karin; Spazzapan, Simon; School of Public Health: Public HealthAdjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a "standard chemotherapy regimen": The CASA randomized trial, The Breast, vol.22, 2, 2013,pp 130-137
2015CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trialCoates, Alan; Abramovitz, Mark; Biasi, Maria Olivia; Bouzyk, Mark; Dell’Orto, Patrizia; et al, Various; Gray, Kathryn P; Kammler, Roswitha; Leyland-Jones, Brian; Long, Bradley; Thurlimann, B.; Young, Brandon; School of Public Health: Public HealthCYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial, Breast Cancer Research and Treatment, vol.151, 2, 2015,pp 373-384
2015ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancerCoates, Alan; Abramovitz, Mark; Biasi, Maria Olivia; Bouzyk, Mark; Dell’Orto, Patrizia; et al, Various; Gray, Kathryn P; Kammler, Roswitha; Leyland-Jones, Brian; Long, Bradley; Thurlimann, Beat; Young, Brandon; School of Public Health: Public HealthESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer, Breast Cancer Research and Treatment, vol.154, 3, 2015,pp 543-555
2016Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trialCoates, Alan; Aristarco, Valentina; et al, Various; Gray, Kathryn P; Johansson, Harriet; Macis, Debora; Pagani, Olivia; Puccio, Antonella; Regan, Meredith; Roux, Susanne; Viale, Giuseppe; School of Public Health: Public HealthImpact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial, Breast Cancer Research, vol.18, 1, 2016,pp 1-12
2012Obesity and Risk of Recurrence or Death After Adjuvant Endocrine Therapy With Letrozole or Tamoxifen in the Breast International Group 1-98 TrialCoates, Alan; Bonnefoi, Herve; Ejlertsen, Bent; et al, Various; Ewertz, Marianne; Forbes, John F.; Gray, Kathryn P; Paridaens, R.J.; Price, Karen N.; Rabaglio, Manuela; Regan, Meredith M.; Thurlimann, Beat; School of Public Health: Public HealthObesity and Risk of Recurrence or Death After Adjuvant Endocrine Therapy With Letrozole or Tamoxifen in the Breast International Group 1-98 Trial, Journal of Clinical Oncology, vol.30, 32, 2012,pp 3967-3975